GAVI Offers Up To $27.5M In Matching Funds To Support Malaria Vaccine Research
Reuters: GAVI alliance offers matched funds for GSK malaria vaccine pilot
“The GAVI global vaccine alliance has offered funding of up to $27.5 million for pilot tests of GlaxoSmithKline’s first-generation malaria vaccine, but only if other organizations promise to match that commitment…” (Kelland, 6/23).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.